Abbvie Inc banner

Abbvie Inc
XBER:4AB

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
XBER:4AB
Watchlist
Price: 197 EUR Market Closed
Market Cap: €230B

Wall St Price Targets

4AB Price Targets Summary
Abbvie Inc

Wall Street analysts forecast 4AB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 4AB is 221.2 EUR with a low forecast of 160.25 EUR and a high forecast of 277.7 EUR.

Lowest Forecast
Price Target
160.25 EUR
19% Downside
Average Forecast
Price Target
221.2 EUR
12% Upside
Highest Forecast
Price Target
277.7 EUR
41% Upside
Abbvie Inc Competitors:
Price Targets
AMP
Amper SA
25% Upside
AYTU
Aytu Biopharma Inc
330% Upside
FAF
First American Financial Corp
5% Upside

Revenue
Forecast

10% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
10% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 5%.

Gross Profit
Forecast

9% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
9% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 7%.

Operating Income
Forecast

10% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss
10% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 8 years is 12%.

Pre-Tax Income
Forecast

1% / Year
Past Growth
82% / Year
Estimated Growth
Estimates Accuracy
-51%
Average Miss
1% / Year
Past Growth
82% / Year
Estimated Growth
Estimates Accuracy
-51%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 82%.

Net Income
Forecast

-2% / Year
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-52%
Average Miss
-2% / Year
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-52%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been -2%. The projected CAGR for the next 8 years is 31%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 4AB's stock price target?
Price Target
221.2 EUR

According to Wall Street analysts, the average 1-year price target for 4AB is 221.2 EUR with a low forecast of 160.25 EUR and a high forecast of 277.7 EUR.

What is the Revenue forecast for Abbvie Inc?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 5%.

What is the Gross Profit forecast for Abbvie Inc?
Projected CAGR
7%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 7%.

What is the Operating Income forecast for Abbvie Inc?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 8 years is 12%.

What is the Pre-Tax Income forecast for Abbvie Inc?
Projected CAGR
82%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 82%.

What is the Net Income forecast for Abbvie Inc?
Projected CAGR
31%

Over the last 13 years, the compound annual growth rate for Net Income has been -2%. The projected CAGR for the next 8 years is 31%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett